Shares of Klaviyo, Inc. (NYSE:KVYO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nineteen ratings firms that are currently covering the company, Marketbeat reports. Five research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $49.89.
KVYO has been the topic of several analyst reports. Morgan Stanley increased their price target on Klaviyo from $47.00 to $50.00 and gave the company an “equal weight” rating in a report on Thursday, February 20th. Needham & Company LLC upped their price target on shares of Klaviyo from $46.00 to $56.00 and gave the company a “buy” rating in a report on Thursday, February 20th. Stifel Nicolaus lifted their price objective on Klaviyo from $45.00 to $54.00 and gave the stock a “buy” rating in a research note on Thursday, February 20th. The Goldman Sachs Group lifted their price target on Klaviyo from $45.00 to $51.00 and gave the stock a “buy” rating in a research report on Thursday, February 20th. Finally, KeyCorp raised their price objective on shares of Klaviyo from $42.00 to $45.00 and gave the stock an “overweight” rating in a research note on Friday, December 13th.
Check Out Our Latest Stock Analysis on KVYO
Insider Buying and Selling
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of KVYO. California State Teachers Retirement System increased its holdings in Klaviyo by 1.8% during the 4th quarter. California State Teachers Retirement System now owns 49,997 shares of the company’s stock valued at $2,062,000 after purchasing an additional 864 shares in the last quarter. Alpha Wealth Funds LLC bought a new position in shares of Klaviyo in the fourth quarter valued at about $209,000. Total Wealth Planning & Management Inc. acquired a new position in Klaviyo during the 4th quarter worth about $397,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Klaviyo by 76.3% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 105,178 shares of the company’s stock worth $4,338,000 after acquiring an additional 45,523 shares during the last quarter. Finally, Voloridge Investment Management LLC increased its position in Klaviyo by 15.7% in the 4th quarter. Voloridge Investment Management LLC now owns 922,832 shares of the company’s stock valued at $38,058,000 after acquiring an additional 125,352 shares in the last quarter. 45.43% of the stock is owned by institutional investors and hedge funds.
Klaviyo Stock Performance
Shares of KVYO opened at $30.95 on Monday. The firm has a market cap of $8.45 billion, a PE ratio of -171.93 and a beta of 0.86. The firm’s 50 day moving average price is $40.57 and its 200 day moving average price is $38.76. Klaviyo has a twelve month low of $21.26 and a twelve month high of $49.55.
Klaviyo (NYSE:KVYO – Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.12). The business had revenue of $270.16 million during the quarter, compared to analyst estimates of $257.24 million. Klaviyo had a negative net margin of 4.92% and a positive return on equity of 0.89%. On average, sell-side analysts anticipate that Klaviyo will post 0.04 earnings per share for the current fiscal year.
About Klaviyo
Klaviyo, Inc, a technology company, provides a software-as-a-service platform in the United States, other Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers Klaviyo, a cloud-native platform for data store, segmentation engine, campaigns and flows, and messaging infrastructure.
Further Reading
- Five stocks we like better than Klaviyo
- What Are Some of the Best Large-Cap Stocks to Buy?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Most active stocks: Dollar volume vs share volume
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- How to Invest in Biotech Stocks
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Klaviyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Klaviyo and related companies with MarketBeat.com's FREE daily email newsletter.